Attached files
| file | filename |
|---|---|
| EX-3.1 - EX-3.1 - CytoDyn Inc. | d271253dex31.htm |
| EX-31.2 - EX-31.2 - CytoDyn Inc. | d271253dex312.htm |
| EX-31.1 - EX-31.1 - CytoDyn Inc. | d271253dex311.htm |
| EX-32.1 - EX-32.1 - CytoDyn Inc. | d271253dex321.htm |
| 10-Q - 10-Q - CytoDyn Inc. | d271253d10q.htm |
Exhibit 32.2
Certification of Chief Financial Officer
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the Quarterly Report of CytoDyn Inc. (the “Company”) on Form 10-Q for the fiscal quarter ended August 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-Q”), I, Michael D. Mulholland, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that based on my knowledge:
| (1) | The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and |
| (2) | The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: October 9, 2020 | /s/ Michael D. Mulholland | |||||
| Michael D. Mulholland | ||||||
| Chief Financial Officer and Treasurer |